CYP3A4-IN-5
CYP3A4-IN-5 (Compound 5p) is a potent Leishmania major pteridine reductase 1 (Lm PTR1) inhibitor (IC50=12.77 µM) . CYP3A4-IN-5 is promising for research of parasite infection[1].
Product Specifications
CAS Number
[70619-09-9]
UNSPSC
12352005
Target
Parasite
Related Pathways
Anti-infection
Applications
COVID-19-immunoregulation
Field of Research
Infection
Smiles
S=C(N/N=C/C1=CC=C(F)C=C1)NC2=CC=CN=C2
Molecular Formula
C13H11FN4S
Molecular Weight
274.32
References & Citations
[1]Molaei S, et al. Synthesis of thiosemicarbazone Schiff base derivatives as anti-leishmanial agents and molecular dynamics simulations insights. Sci Rep. 2025 Jul 10;15 (1) :24867.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS6238912-01 0.1 mL
IL1B (Interleukin 1, beta, IL-1, IL1-BETA, IL1F2) (MaxLight 750)
Ask
View Details MBS6238912-02 5x 0.1 mL
IL1B (Interleukin 1, beta, IL-1, IL1-BETA, IL1F2) (MaxLight 750)
Ask
View Details 